What if it was actually possible to cure ourselves of illnesses with nothing more than our body’s own natural mechanisms? How threatening would that be to big pharma companies and researchers? Literally a whole industry could very well collapse.
GcMAF (Glycoprotein Macrophage Activating Factor) is a protein made by our body and is pretty much the ‘director’ of our immune system. Our immune system is our bodies defence system against viruses and other pathogens. As healthy persons we all produce thousands of cancer cells every day. Think about it, we are all in constant contact with so many different surfaces and substances, that usually have been touched, held, passed, excreted, or felt by another or many living beings. Viruses and bacteria can easily find their way inside our bodies. In a sense, cancer is much more present to us than we think. But because we have a protein called GcMAF those cancer cells are destroyed every day. It activates our bodies macrophages, which are cells originating from monocytes, a type of white blood cell. It would make sense then for the immune system of a healthy person to be robust and strong, given how often we are exposed to such dangers. If we’re stressed out or anxious about something, however, our immune efficiency is greatly compromised, making it much easier for a virus or disease to successfully attack. When this happens, a protein called Nagalease is sent out which blocks our GcMAF. The result is usually illness.
According to First Immune, GcMAF has about 20 beneficial attacks on disease, including 6 on cancer cells. Tests and studies are currently underway by the FDA and Phase I should be completed by 2016. The Anticancer Fund has stated that GcMAF has not been properly studied in clinical trials and its laboratory results still need to be confirmed independently. However, there are thousands of people around the world that are trying GcMAF as a possible natural remedy to various illnesses. The late Dr. Jeff Bradstreet saw many patients with autism. He treated 1,100 patients with GcMAF with an 85% response rate. His results show a bell curve response, with 15% of the patients showing total eradication of symptoms and 15% showing no response.
Although governments aren’t satisfied with the current level of research out there about GcMAF, Bradstreets’s results were enough for individuals to still seek out treatment.